OWEN MUIR to Humans
This is a "connection" page, showing publications OWEN MUIR has written about Humans.
Connection Strength
0.178
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview. Am J Ther. 2024 Mar-Apr 01; 31(2):e97-e103.
Score: 0.018
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD). Am J Ther. 2024 Mar-Apr 01; 31(2):e104-e111.
Score: 0.018
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca. Am J Ther. 2024 Mar-Apr 01; 31(2):e112-e120.
Score: 0.018
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin. Am J Ther. 2024 Mar-Apr 01; 31(2):e121-e132.
Score: 0.018
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine. Am J Ther. 2024 Mar-Apr 01; 31(2):e133-e140.
Score: 0.018
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA). Am J Ther. 2024 Mar-Apr 01; 31(2):e141-e154.
Score: 0.018
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine. Am J Ther. 2024 Mar-Apr 01; 31(2):e155-e177.
Score: 0.018
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics. Am J Ther. 2024 Mar-Apr 01; 31(2):e178-e182.
Score: 0.018
-
Mental health clinicians' attitudes toward narcissistic personality disorder. Personal Disord. 2021 09; 12(5):389-399.
Score: 0.015
-
Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis. Psychiatry Res. 2023 06; 324:115179.
Score: 0.004
-
Long-term outcomes of a course of deep TMS for treatment-resistant OCD. Brain Stimul. 2022 Jan-Feb; 15(1):226-228.
Score: 0.004
-
Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites. J Psychiatr Res. 2021 05; 137:667-672.
Score: 0.004
-
Blogging and Social Media for Mental Health Education and Advocacy: a Review for Psychiatrists. Curr Psychiatry Rep. 2015 Nov; 17(11):88.
Score: 0.003
-
When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophr Res. 2012 Feb; 134(2-3):180-6.
Score: 0.002